Bioceltix S.A. (WSE:BCX)
Poland
· Delayed Price · Currency is PLN 118.00
-0.80 (-0.67%)
May 13, 2025, 2:31 PM CET
Bioceltix Market Cap
Bioceltix has a market cap or net worth of 585.03 million as of May 13, 2025. Its market cap has increased by 99.82% in one year.
Market Cap
585.03M
Enterprise Value
547.77M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
118.00
Market Cap Chart
Since November 8, 2021, Bioceltix's market cap has increased from 115.04M to 585.03M, an increase of 408.55%. That is a compound annual growth rate of 58.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 585.03M | 35.62% |
| Dec 30, 2024 | 431.38M | 16.07% |
| Dec 29, 2023 | 371.65M | 179.48% |
| Dec 30, 2022 | 132.98M | -22.49% |
| Dec 30, 2021 | 171.57M | 49.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NEUCA | 3.21B |
| Synektik Spólka Akcyjna | 1.95B |
| Voxel | 1.69B |
| Celon Pharma | 1.27B |
| Ryvu Therapeutics | 774.52M |
| Selvita | 640.61M |
| Centrum Medyczne ENEL-MED | 565.61M |
| EMC Instytut Medyczny | 469.52M |